OR WAIT null SECS
November 27, 2024
Article
Patients in the anifrolumab arm also had lower rates of damage accrual.
November 25, 2024
Hypovitaminosis D was more prevalent in patients with lupus nephritis compared to patients with systemic lupus erythematosus without kidney disease.
November 24, 2024
Video
Arnold discussed his research in analyzing and improving current classifications of ANA-RMDs and how it could help improve research in the field.
November 21, 2024
Clowse discussed findings from the phase 3 PHOENYCS GO trial presented at the 2024 ACR Convergence.
November 19, 2024
The phase 3 PHOENYCS GO trial met its primary endpoint in achieving BICLA response at week 48 compared with placebo.
November 16, 2024
Schett discussed findings from 2 early studies of CD19 CAR T-cell therapy.
A-319 has been well-tolerated so far and dose-escalation is ongoing in the phase 1 trial.
October 29, 2024
Four of 5 participants with follow-up reaching 3 months have achieved SRI-4 disease responses.
October 13, 2024
A study found that high ultraprocessed food consumption increases the risk of SLE by 56%, with an even higher risk for anti-dsDNA positive SLE at 105%.
September 25, 2024
The therapy demonstrated superior efficacy in combination with SOC over SOC alone.
